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Abstract 
Synthesis, Characterization, and Reactivity Studies of para-Substituted 
Triaryltin Cobaloximes 
Elizabeth Marie Ward 
 Several six-coordinate cobaloxime compounds containing a triaryltin ligand were 
synthesized and characterized. These cobaloximes include (4-t-BuPy)Co(DH)2Sn(C6H4-p-
tolyl)3, (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3, (NH3)Co(DH)2SnPh3, and (4-t-
BuPy)Co(DH)2Bn. (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 crystallized in the 
centrosymmetric triclinic space group P-1 (Z=4) with unit cell dimensions a = 13.2949(5) 
Å, b = 17.7508(7) Å, c = 18.2240(7) Å, α = 107.1983(13)º, β = 91.6597(13)º, γ = 
107.6992(12)º, and Volume = 3880.5(3) Å3. The structure was isostructural with other 
alkyl cobaloximes. Preliminary X-ray structure analysis determined that 
(NH3)Co(DH)2SnPh3 had a NH3 ligand bound to the six-coordinate octahedral cobalt center 
and trans to the triaryltin ligand. The para-substituted cobaloximes were synthesized 
through a Gringard reaction to obtain the tetraaryltin species, SnAr4, followed by an 
adapted Jolly redistribution procedure to obtain the triaryltin chloride species, ClSnAr3. 
The SnAr4 compounds synthesized were Sn(C6H4-p-tolyl)4, Sn(C6H4-p-t-Bu)4, and 
Sn(C6H4-p-OCH3)4. The ClSnAr3 complexes synthesized successfully were ClSn(C6H4-p-
tolyl)3 and ClSn(C6H4-p-t-Bu)3. These ClSnAr3 complexes were used as the tin ligand to 
synthesize the corresponding cobaloxime compounds. Once synthesized, the cobaloximes 
underwent halogen cleavage titrations to investigate the effects of changes in the 
cobaloxime coordination environment and to compare their reactivity to that of the 
CoIII(OEP)SnPh3. The multiple products formed through these halogen cleavage reactions 
indicates that the Co-Sn bond is not cleaved cleanly for these cobaloximes, unlike the 
porphyrins compounds. The cobaloximes react with the halogens to first cleave the Sn-C 
bonds through electrophilic aromatic substitution, indicating that cleavage of the Sn-C 
bond is more facile than cleavage of the Co-Sn bond in these compounds.  
 iii 
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1.1 Thesis Overview 
The objective of this thesis project is to develop a cobaloxime with a Co-Sn bond that will 
exhibit clean cleavage through oxidation with halogen. The cobaloxime environment will be 
tuned in order to gain more insight into the structure and possibly the reactivity of the 
cobaloxime. This project involves changing the substituents on the phenyl ring of the triaryltin 
group of the cobaloxime and also work on modifying the Lewis base ligand and attempts to 
change the group 14 element bound to the cobalt center. The setup of this thesis begins with an 
introduction into the history of vitamin B12, its structure, work done to investigate factors 
affecting the Co-C bond, model compounds for vitamin B12, and work done by the Stolzenberg 
group that provides the basis for this project. Following the introduction, the experimental 
section will cover the synthesis of the compounds used in this project. Finally, the results and 
discussion and concluding remarks are presented. 
1.2 Project Background  
Vitamin B12 (cyanocobalamin), seen in Figure 1 with R = CN, is a bioinorganic naturally 
occurring molecule that has been investigated by many different disciplines such as medicine, 
agriculture, biochemistry, microbiology, organic and inorganic chemistry, X-ray crystallography, 
theoretical chemists, etc.1 The interest in vitamin B12 has its beginnings in medicine as a 
treatment for pernicious anemia in the 1920’s using liver therapy. The use as a therapy preceded 
the isolation of the compound in 1948 by Folkers at Merck and by Smith and Parker at Glaxo 
Laboratories. 2-4 Following this, the coenzyme was isolated in 1958 by Barker and associates.5 
The majority of the structure was unknown, but the X-ray crystal structure was solved in 1961 by 
 
2 
Dorothy Hodgkin. Her work revealed the presence of two structures that were previously 
unknown in nature: the corrin ring (seen in Figure 2) and the Co-C bond which was the first 
known naturally occurring organometallic compound.1 This relatively inert bond between cobalt 
and a primary alkyl ligand is especially interesting due to its stability under physiological 
conditions.6 
 
 Vitamin B12 belongs to a class of compounds called cobalamins, where the heterocyclic 
base is 5,6-dimethylbenzimidazole. Figure 1 above shows the structures of vitamin B12 also 
known as cyanocobalamin (CNCbl, R=CN), adenosylcobalamin (AdoCbl, R=5’-deoxyadenosyl), 
and methylcobalamin (MeCbl, R=Me).7-8  The six-coordinate cobalt atom exhibits an octahedral 
Figure 1: General Cobalamin Structure where R = 5’-
deoxyadenosyl, CN, or Me 
 
3 
structure that is bound axially by the R group, nitrogen on the benzimidazole, and by four donor 
nitrogen atoms of the corrin ring in the equatorial plane. The six-coordinate arrangement exhibits 
a tetragonal distortion and the corresponding splitting pattern of the d-orbitals is observed.6 The 
corrin ring, conjugated system of double bonds, creates a strong ligand field resulting in low spin 
cobalt and differs slightly from the more widely known porphyrin ring by directly binding two of 
the rings, as seen in Figure 2.9-10 The four donor nitrogen atoms of the corrin ring are not 
coplanar with the cobalt atom, as is seen in the porphyrin complex.7 The Co-N bond to the 
benzimidazole is longer than the Co-N bonds in the equatorial plane. The cleavage of the Co-C 
bond is important in the enzymatic reactions of the coenzymes. The Co-C bond is stable towards 
hydrolysis, but still weak enough to be cleaved readily by enzymatic reactions. This interesting 
behavior led chemists to study these complexes and the reactivity of the metal-alkyl bond 
specifically.7, 11-12 
 
  To understand the enzymatic reactions of the coenzymes, it is important to gain 
understanding into the Co-C bond and how readily it gets cleaved. This led to investigating the 
variability of the Co-C bond length and what factors affect it, such as the nature of the axial 
Figure 2: Corrin ring (left) versus porphyrin ring (right) 
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ligands trans to each other. In order to more easily probe the structure of the cobalamins, model 
compounds were developed and a sampling of those models including Schiff bases such as 
Co(Saloph)R and Co(Salen)R, alkyl cobalt porphyrins, and cobaloximes (seen in Figure 3).  
 
 In 1964, Schrauzer and Kohnle introduced cobaloximes, named for their similarities to 
cobalamins with the general form (Base)Co(DH)2R, where DH is the dimethylglyoxime ligand 
(seen in Figure 3). 13 These Co(III) complexes consist of two dimethylglyoxime ligands 
(abbreviated DMG) that are linked through O—H⸱⸱⸱O hydrogen bonds. The axial positions 





















Figure 3: Models for the cobalt center of Vitamin B12 
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cobaloxime was studied by Lenhert in 1967 and has the structure (Py)Co(DH)2CH2COOCH3. It 
was characterized by X-ray crystallography to confirm the structure of the cobaloxime and 
compare the bond distances and angles to the coenzyme. 14 The four donor nitrogen atoms lie in 
the plane with the Co atom, as opposed to the slightly distorted plane of the cobalamins. The 
equatorial Co-N bond distances of the cobaloxime averaged 1.88 Å, very similar to the 
coenzyme (1.90 Å). The axial bond lengths for the Co-N and Co-C in the cobaloxime are both 
~2.04 Å, whereas the Co-C and axial Co-N of the coenzyme are 2.03 Å and 2.24 Å respectively. 
The axial Co-N bond in the cobaloxime is significantly shorter than that of the coenzyme, 
resulting from the slightly more positive cobalt center in the cobaloxime.7 Among the series of 
synthesized cobaloximes, the DMG ligands and cobalt atom have similar bond lengths and 
angles with some variability in the bridging H location, but the lengths to the axial substituents 
will vary greatly.  
 The main reason for this variability in the axial bond lengths is the trans effect.15-17 This 
arises from the effect of the axial electron donating base on the axial alkyl group and resulting 
Co-C bond trans to it. This effect can be seen in the cobalamins and the changes in the axial Co-
N bond of the benzimidazole. When the group trans to benzimidazole is the CN group of vitamin 
B12 the bond length is 1.97 – 2.06 Å, but when the group trans to the benzimidazole is the 
adenosyl group of AdoCbl the Co-N bond length is 2.24 Å, indicating a weaker bond to the 
benzimidazole. This could indicate that when the bond from the cobalt center to the 
benzimidazole is replaced upon binding to the protein, the nature of the group (side chain on 
protein) that binds the cobalt could control the cleavage of the Co-C bond trans to it through its 
electron withdrawing properties.  
 
6 
 This trans effect was studied further through cobalamin models. Elder and coworkers 
investigated this effect first using pentammine cobalt complexes, [Co(NH3)5X] and found that 
the equatorial Co-N bonds were similar in length to the cobalamins, but the axial Co-N bond 
length depends on the nature of the X ligand trans to it.18-22 Elder and coworkers then extended 
their work to cobaloximes and found a correlation between the structural and kinetic trans effects 
indicating bond lengthening could correlate to reactivity. Randaccio and Marcilli analyzed 
several series of cobaloximes and their geometries. They found that for the same phosphine, 
(PPh3)Co(DH)2X for example, as the σ donating ability of the trans ligand increases the Co-P 
bond will shorten with X being electron withdrawing and will lengthen with X being electron 
donating.23 They also found that the substituents on the C of the alkyl group attached to the 
cobalt can also have trans influencing effects, with an electron withdrawing substituent 
weakening the trans influence and an electron donating substituent strengthening the trans 
influence. Also they found that in the series of cobaloximes, the nature of the base will also 
effect the trans influence, with P-donor Lewis bases having a greater influence than the N-donor 
Lewis bases. 
 Sterics can also affect the bond lengths of the axial alkyl group and base to the cobalt 
center. In cobaloximes, non-bulky axial ligands will allow the Co atom to sit nearly coplanar 
with the four donor nitrogen atoms. Bulky axial ligands will displace the cobalt atom from the 
plane of the DMG ligands, moving the cobalt towards the bulky ligand and bending the DMG 
ligands away from the bulky axial ligand.7 In phosphine cobaloximes, for the same axial trans 
ligand, the length of the Co-P bond will fall between 2.165 – 2.418 Å.24 The effects of increasing 
the bulk (cone angle) of the phosphine ligand were that the Co-P bond lengthens, the cobalt atom 
displaces toward the P, also the Co-C bond will lengthen with the increase in the bulk of the 
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phosphine ligand trans to it. Marzilli, Randaccio and coworkers were able to demonstrate a linear 
relationship between the length of the Co-C bond and the number of non-hydrogen substituents 
on the C of the alkyl group bound to the cobalt center in (Py)Co(DH)2X cobaloximes.23 Ohashi 
found similarly that this lengthening will also occur with substituents that are not simple alkyl 
groups, but the relationship will be exponential instead of linear. To summarize the effects of 
steric bulk on the alkyl-cobalt bond: small axial ligands will lead to a short Co-C and the cobalt 
ion being coplanar with the DMG ligands, a bulky base will cause the DMG ligands to bend 
towards the alkyl group and lengthen the Co-C slightly, and lastly a bulky substituent on the 
alkyl group bound to carbon leads to a lengthening of the Co-C bond and an increase in the Co-
C-R bond angle due to an increase in steric interactions between the R substituent and the DMG 
ligands. This increase in substituent bulk leading to the lengthening of the Co-C bond is also 
seen in the Co-CH2-C bond angle in the coenzyme B12 with analogous steric interactions with the 
corrin ring. These steric interactions cause strain and therefore help promote the cleaving of the 
Co-C bond.        
1.3 Basis of Current Project 
Stolzenberg has done extensive research involving the synthesis, characterization, and 
reactivity studies of organocobalt porphyrins.25-29  These organocobalt porphyrins can also be 
used as models for vitamin B12. The reactivity of the Co-E bond, where E is a group 14 element, 
was investigated. In 2001, Cao and Stolzenberg synthesized CoIII(OEP)SnPh3, where OEP is 
octaethylporphyrin, and found that it was unexpectedly inert when compared to the alkyl 
porphyrin. The synthesis of the porphyrin is seen in Scheme 1. This stability of the 
CoIII(OEP)SnPh3 raises questions about why the Co-Sn bond is stronger than the Co-C bond in 
this system. The CoIII(OEP)SnPh3 has a slow rate of homolysis and is stable to thermal 
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decomposition. The Co-Sn bond of the porphyrin can be readily cleaved by oxidation with a 
halogen or photolysis (Scheme 1).  
 
 The interesting reactivity of the porphyrins prompted investigation into bond strengths of 
the group 14 analogues. With this in mind, a larger quantity of material would be needed to 
perform the necessary experiments and with the low yield syntheses of the organocobalt 
porphyrins, this was not feasible. The switch to cobaloximes, another vitamin B12 model came 
after finding a series of compounds synthesized by Schrauzer of the form (Py)Co(DH)2EPh3, 
where E = Si, Ge, Sn, and Pb.30-31 He reported the complexes to have good thermal and moderate 
air stability, for the tin and lead cobaloximes, but the reactivity of these compounds was not 
investigated. In 2007, Stolzenberg and co-workers.32 synthesized the 4-t-BuPy analogues of the 
SnPh3 and PbPh3 cobaloximes and were able to obtain crystal structures and some reactivity data 
for them. The 4-t-butylpyridine (4-t-BuPy) was used in placed of pyridine (Py) to improve 
solubility and simplify the 1H NMR spectra of the synthesized compounds.33-35 The germanium 
and silicon analogues were unable to be synthesized due to poor solubility and other issues.  
 Halogen cleavage reactions were performed on the (4-t-BuPy)Co(DH)2SnPh3 and the (4-
t-BuPy)Co(DH)2PbPh3 and found that clean cleavage of the Co-E bond did not occur. This 
outcome is very different from the reaction of the organocobalt porphyrin with halogen. This 
difference in reactivity of the porphyrin and cobaloxime complexes containing Co-Sn bonds is 
the basis for this project. The goal of this work is to find a cobaloxime system that, through 







Scheme 1: Synthesis of Co
III
(OEP)SnPh3 and its oxidation with Iodine 
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into the differences in reactivity of these two cobalamin model compounds. There are several 
ways to change the ligand environment to tune the reactivity: changing the size or strength of the 
base, changing the group 14 element (E) bound to the cobalt center, changing the substitution on 
the triaryltin ligand, or looking into another 5 coordinate system (like Schiff bases or a labile 
base that can be easily removed to form a 5 coordinate cobaloxime) to compare to the 5 
coordinate porphyrin. The approach that is taken in this project is to change the substitution of 
the triaryltin ligand by adding a substituent to the para position of the phenyl ring. Our 
hypothesis is that the halogen is cleaving the Sn-C on the phenyl ring as opposed to the desired 
Co-Sn bond cleavage and that by substituting onto the para position of the phenyl ring may 
change the donor strength enough to promote Co-Sn cleavage. To test this hypothesis, 
tetraaryltin compounds were synthesized with -CH3, -OCH3, and -tBu substituted in the para 
position of the phenyl ring. The next step was to perform a redistribution reaction to obtain the 
substituted chloro triaryl tin compounds which were then reacted with (4-t-BuPy)Co(DH)2Cl to 
form the desired cobaloximes. The cobaloximes then underwent halogen cleavage reactions and 
their products analyzed.  
2.0 Experimental 
2.1 Materials and Methods 
All reactions were carried out under a nitrogen atmosphere using Schlenk techniques, unless 
otherwise noted. The Co(DH)(DH2)Cl236, (Py)Co(DH)2SnPh3, (4-t-BuPy)Co(DH)2Cl36, and (4-t-
BuPy)Co(DH)2SnPh332, 37 were prepared using literature methods. The cobaloxime (4-
CNPy)Co(DH)2SnPh3 was previously synthesized by a member of the Stolzenberg group. The 
cobalt ammine complex, [Co(NH3)5Cl]Cl2, was synthesized in the Inorganic Synthesis lab 
(Chem 423) at West Virginia University, but is available commercially. All solvents and 
 
10 
compounds used in the syntheses were reagent grade or the best available. All commercially 
available compounds were used as received. Deuterated solvents, CDCl3, C6D6, DMSO and 
CD3CN, were passed through a column of activated alumina prior to use. 1H NMR spectra were 
recorded on a JEOL Eclipse 270 MHz, Agilent 400 MHz, and Varian INOVA 600 MHz NMR 
spectrometers. The chemical shifts (δ) are given in parts per million and referenced to internal 
TMS (0 ppm) or residual protio solvent (7.26 for CDCl3, 7.16 for C6D6, 2.50 for DMSO and 1.94 
for CD3CN). The GC/MS samples were run in benzene and the commercial compounds 1-
bromo-4-tertbutylbenzene, 4-bromotoluene, and 4-iodotoluene were run under the same 
conditions to compare the retention times to our compounds.  
2.2 Syntheses 
2.2.1 Synthesis of tetraaryltin complexes, SnAr4 
The tetraaryltin complexes have four para-substituted phenyl rings attached to a tin 
center. The substituents used on the phenyl rings are p-tolyl (-CH3), p-anisole (-OCH3), and p-
tertbutyl (-t-Bu). The three compounds were synthesized using the same procedure and 1H NMR 
shifts and melting points of the recrystallized compounds were consistent with literature values. 
The following procedure was used for the synthesis of Sn(C6H4-p-tolyl)4.  
This synthesis was carried out under nitrogen using Schlenk techniques and the glassware 
and magnesium turnings were oven dried overnight to limit moisture exposure during the 
Grignard reaction. A combination of 12.26 g of 4-bromotoluene and 1.77 g of magnesium 
turnings were added to 105 mL of THF. An addition funnel attached to the reaction flask 
contained a portion of the 4-bromotoluene and 25 mL of THF. The reaction was brought up to 
reflux and the contents of the addition funnel were added slowly, along with two crystals of I2. 
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Upon addition of the iodine, the solution turned orange-brown, then slowly lightened in color as 
the reaction heated up until the color finally dissipated and a colorless solution remained. The 
solution was held at reflux for three hours. The procedure calls for the solution to be transferred 
under nitrogen away from any unreacted magnesium, but there was no unreacted magnesium at 
this point. The flask was cooled in an ice bath and 1.26 mL of SnCl4 was added through the top 
of the reflux condenser. Some white smoke was observed upon addition, along with some white 
solid (MgCl2) on the top of the liquid when the ice bath was removed. The flask was heated back 
to reflux and allowed to reflux. After 20 hours of reflux, an amber colored liquid was observed. 
Upon addition of 35 mL of 1 M HCl, the solution turned white and then heated slightly. The 
white solid dissolved and left an amber colored liquid layer on top and a colorless clear layer on 
the bottom of the flask. The flask was placed in ice and after about 20 minutes, a white solid 
began to form at the interface between the two liquid layers. As the flask remained in the ice 
longer, more solid began to form. The flask was placed in the freezer overnight to facilitate 
product formation. The solution was filtered and the filtrate saved for a second crop. The filtered 
solid was washed with 25 mL of methanol, followed by 50 mL of 1 M HCl and another 25 mL of 
methanol. 1.65 g of white solid was collected for crop 1. From the second crop, another 1.88 g of 
white solid was obtained. Crop 1 was recrystallized from warm toluene layered with ethanol. Its 
melting point was 235.3 – 236.4 ºC, which is consistent with literature. The 1H NMR is also 
consistent with literature values. (67% yield) 1H NMR (CDCl3): δ 2.37 (s, 12 H), 7.21 (dd, 8 H), 
7.49 (dd, 8 H) 
Sn(C6H4-p-OCH3)4: (39% yield) 1H NMR (CDCl3): δ 3.80 (s, 12 H), 6.87 (dd, 8 H), and 7.39 
(dd, 8 H) 
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Sn(C6H4-p-tBu)4: (47% yield) 1H NMR (C6D6): δ 1.23 (s, 27 H), 7.33 (dd, 8 H), and 7.75 (dd, 8 
H)  
2.2.2 Synthesis of chlorotriaryltin complexes, ClSnAr3  
The tetraaryltin complexes undergo a redistribution in order to obtain the chlorotriaryltins. 
The following procedure details the synthesis of ClSn(C6H4-p-t-Bu)3. The same procedure was 
used to synthesize ClSn(C6H4-p-tolyl)3 with similar observations, but redistribution attempts of 
ClSn(C6H4-p-OCH3)3 were unsuccessful.  
ClSn(C6H4-p-t-Bu)3 was synthesized using 1/20 of the quantities from the Jolly procedure.38  
A mass of 1.60 g (0.0025 mol) Sn(C6H4-p-t-Bu)4 was combined with 0.1 mL (0.00085 mol) 
SnCl4 in the reaction tube and placed in an oil bath. The temperature was raised to 230 ºC over a 
45-minute period. The temperature remained at 233 ºC for three hours. After this time, the 
mixture in the reaction tube had dissolved. The temperature was dropped to 100 ºC and the 
solution was poured into a beaker and allowed to cool to room temperature. The tan solid was 
broken up after cooling and stirred with 200 mL of ethanol at ~ 50 ºC. About 500 mL of water 
was added slowly to the ethanolic solution and a white solid crashed out of solution. The flask 
was placed in a refrigerator for 30 minutes to promote solid formation. The solid was filtered and 
a relatively pure compound was obtained. (67% yield) 1H NMR (C6D6): δ 1.19 (s, 27 H), 7.30 
(dd, 6 H), and 7.70 (dd, 6 H) 





2.2.3 Synthesis of (NH3)Co(DH)2Cl 
In an Erlenmeyer flask, 4.00 g of dimethylglyoxime (DMG), 5.02 g [Co(NH3)5Cl]Cl2, 40 
mL of water and 15.04 g of ammonium acetate were combined and stirred. Approximately 2 mL 
of concentrated acetic acid was added to the flask. The flask was then heated in a water bath, 
keeping the temperature below 100 ºC. After five minutes, the solution turned brown and NH3 
gas was detected by litmus paper. More acetic acid was added to the flask, about 8 mL in total, 
until no more ammonia gas was able to be detected. The flask continued to heat to dissolve the 
DMG. After 10 minutes, the solution was filtered and the filtrate was reduced to a small volume. 
The filtrate was filtered and the solid was combined with the previous crop of solid and washed 
with cold distilled water. The solid was then heated in 25 mL of ethanol to remove the 
undissolved DMG. The solution was filtered, and the crude solid was allowed to air dry. The 
crude product was then recrystallized from hot water with a drop of acetic acid. Crop one 
resulted in 3.00 g of product and the 1H NMR was obtained. Crop two resulted in 0.75 g of 
brown needles. (55% yield) 1H NMR (DMSO): δ 1.92 (s,3 H), 2.27 (s, 12 H), and 18.46 (s, 2 H) 
2.2.4 Synthesis of Cobaloximes Using One-Step Synthesis 
The one-step cobaloxime procedure was used to synthesize (NH3)Co(DH)2SnPh3 and (4-
t-BuPy)Co(DH)2Bn.39 For the synthesis of the benzyl cobaloxime, benzyl chloride was used 
instead of ClSnPh3. 
In a Schlenk flask 1.0 g (NH3)Co(DH)2Cl, 1.0 g ClSnPh3 and 20 mL of a 1:1 (v:v) 
methanol and water solution were combined and stirred. The flask was degassed and backfilled 
with nitrogen. Over a period of 15 minutes, 0.52 g of NaBH4 was added to the flask in 3 
portions. Upon addition of the NaBH4, the solution turned a reddish brown color. After 10 
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minutes, the solution was filtered and washed with methanol and the filtrate set aside. The solid 
was washed with ether and hexanes and 0.58 g of orange solid product was obtained in crop one. 
The second crop crashed out of the filtrate upon sitting and was filtered, washed with ether and 
hexanes, and the 0.43 g of lighter orange solid product was obtained. (50 % yield) 1H NMR 
(C6D6): δ 0.13 (s, 3 H), 1.66 (s, 12 H), 7.13 (m, 4 H), 7.60 (m, 2 H), 7.78 (dd, 6 H), 19.20 (br., 2 
H) 
(4-t-BuPy)Co(DH)2Bn: (62 % yield), 1H NMR (C6D6): δ 0.64 (s, 9 H), 1.73 (s, 12 H), 3.32 (s, 2 
H), 6.55 (dd, 2 H), 6.98 (t, 2 H), 7.03 (dd, 1 H), 7.39 (dd, 2 H), 8.83 (dd, 2 H), 19.52 (s, 2 H) 
2.2.5 Synthesis of Cobaloximes Using Regular Synthesis32, 36-37 
These compounds were synthesized using the same procedure as the previously reported (4-t-
BuPy)Co(DH)2SnPh332, 37 using (4-t-BuPy)Co(DH)2Cl36 synthesized from literature methods and 
the ClSn(C6H4-p-tolyl)3 and ClSn(C6H4-p-t-Bu)3 obtained from the redistribution procedure 
outlined in the above section.  
(4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3: (56% yield) 1H NMR (CDCl3): δ 1.25 (s, 9 H), 1.72 (s, 12 
H), 2.30 (s, 9 H), 7.09 (dd, 6 H), 7.25 (dd, 2 H), 7.39 (dd, 6 H), 8.40 (dd, 2 H), 18.56 (br, 2 H) 
(4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3: (59% yield) 1H NMR (C6D6): δ 0.64 (s, 9 H), 1.22 (s, 36 
H), 1.63 (s, 12 H), 6.56 (dd, 2 H), 7.28 (dd, 6 H), 7.95 (dd, 6 H), 8.92 (dd, 2 H), 19.74 (br, 2 H) 
2.3 X-ray Structure Analysis  
2.3.1 Analysis for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 
A light orange crystal of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 was washed with the 
perfluoropolyether PFO-XR75 (Lancaster) and wedged in a glass capillary.  The sample was 
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optically aligned on a Bruker AXS D8 Venture fixed-chi X-ray diffractometer equipped with a 
Triumph monochromator, a Mo Kα radiation source (λ = 0.71073 Å), and a PHOTON 100 
CMOS detector.  Two sets of 12 frames each were collected using the omega scan method with a 
10 s exposure time.  Integration of these frames followed by reflection indexing and least-
squares refinement produced a crystal orientation matrix for the triclinic crystal lattice.   
Data collection consisted of the measurement of a total of 1840 frames in five runs using omega 
scans with the detector held at 5.00 cm from the crystal.  The total exposure time was 10.22 hours.  
Frame scan parameters are summarized in Table 1 below: 
Table 1: Data collection details for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3.  
Run 2θ ω φ χ Scan Width (º) Frames  Exposure Time (sec) 
1 11.01 -170.99 144.00 54.74 0.50 368 20.00 
2 11.01 -170.99 0.00 54.74 0.50 368 20.00 
3 11.01 -170.99 -144.00 54.74 0.50 368 20.00 
4 11.01 -170.99 -72.00 54.74 0.50 368 20.00 
5 11.01 -170.99 72.00 54.74 0.50 368 20.00 
 
The APEX2 software program (version 2014.1-1)40 program was used for diffractometer 
control, preliminary frame scans, indexing, orientation matrix calculations, least-squares 
refinement of cell parameters, and the data collection.  The frames were integrated with the Bruker 
SAINT software package using a narrow-frame algorithm. The integration of the data using a 
triclinic unit cell yielded a total of 97231 reflections to a maximum θ angle of 27.50° (0.77 Å 
resolution), of which 17647 were independent (average redundancy 5.510, completeness = 99.0%, 
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Rint = 5.76%, Rsig = 5.79%) and 11275 (63.89%) were greater than 2σ(F2). The final cell constants 
of a = 13.2949(5) Å, b = 17.7508(7) Å, c = 18.2240(7) Å, α = 107.1983(13)°, β = 91.6597(13)°, γ 
= 107.6992(12)°, volume = 3880.5(3) Å3, are based upon the refinement of the XYZ-centroids of 
9877 reflections above 20 σ(I) with 4.703° < 2θ < 54.95°. Data were corrected for absorption 
effects using the multi-scan method (SADABS). The ratio of minimum to maximum apparent 
transmission was 0.701. The calculated minimum and maximum transmission coefficients (based 
on crystal size) are 0.659 and 0.885. 
The structure was solved by direct methods and difference Fourier analysis using the programs 
provided by SHELXL-2013.41 The crystallographic asymmetric unit contains two independent 
molecules of the cobalt complex.  Idealized positions for the hydrogen atoms were included as 
fixed contributions using a riding model with isotropic temperature factors set at 1.2 times 
(aromatic hydrogens) or 1.5 (methyl hydrogens) times that of the adjacent carbon atom.  The 
positions of the methyl hydrogen atoms were optimized by a rigid rotating group refinement with 
idealized angles. The fractional coordinates and the isotropic thermal parameters of the two O-
bound hydrogen atoms in each molecule were refined.  The t-butyl substituent containing carbon 
atoms, C52-C55, suffers from a two-site Star-of-David disorder.  The fractional coordinates and 
anisotropic thermal parameters for C53, C54, and C55 in both sites were independently refined 
with the six C52-C(methyl) distances restrained to 1.52 ± 0.01 Å. Full-matrix least-squares 
refinement, based upon the minimization of  Σwi |Fo2 - Fc2|2, with weighting wi-1 = [σ2(Fo2) + 
(0.0160 P)2 + 6.5059 P], where P = (Max (Fo2, 0) + 2 Fc2)/3.2 The final anisotropic full-matrix 
least-squares refinement on F2 with 950 variables converged at R1 = 6.47%, for the observed data 
and wR2 = 9.56% for all data. The goodness-of-fit was 1.103. The values of R1, wR2, and the 
goodness-of-fit (GOF) were determined using the following equations: R1 = Σ(||Fo| - |Fc||) / Σ |Fo|, 
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wR2 = [Σ [w(Fo2 - Fc2)2] / Σ [w(Fo2)2]]1/2, and GOF = [Σ [w(Fo2 - Fc2)2] / (n-p)]1/2, where n 
is the number of reflections and p is the total number of parameters which were varied during the 
last refinement cycle.  
A correction for secondary extinction was not applied.  The largest peak in the final difference 
electron density synthesis was 1.054 e-/Å3 and the largest hole was -0.657 e-/Å3 with an RMS 
deviation of 0.091 e-/Å3. The linear absorption coefficient, atomic scattering factors, and 
anomalous dispersion corrections were calculated from values found in the International Tables 
of X-ray Crystallography.42 
2.3.2 Preliminary X-ray Analysis for (NH3)Co(DH)2SnPh3 
An X-ray structural analysis was also performed to confirm the molecular structure and 
composition of (NH3)Co(DH)2SnPh3. However, the quality of the structural analysis was limited 
by the presence of unidentified disordered solvent molecules in the lattice. The analysis was 
sufficient to establish the atom connectivity and coordination of NH3. 
2.4 Halogen Cleavage Titrations 
Halogen cleavage titration reactions were completed for the following compounds: 
(Py)Co(DH)2SnPh3, (4-t-BuPy)Co(DH)2SnPh3, (NH3)Co(DH)2SnPh3, (4-CNPy)Co(DH)2SnPh3, 
(4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3, and (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. A former 
group member also ran a halogen cleavage titration with (4-t-BuPy)Co(DH)2Sn(n-Bu)3. In 
general, the halogen used was either I2 or Br2. 
The first step was to determine how many equivalents of halogen would be desired for each 
sample (for example 0, 0.25, 0.5, 0.75, 1 and 2 equivalents of halogen) and calculate the amount 
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of cobaloxime required to end up with approximately 5 mg of sample in each NMR tube. The 
cobaloxime was dissolved in a deuterated solvent and diluted to a known volume in a volumetric 
flask. This gave the known concentration of the cobaloxime and 1 mL of this solution was placed 
in every test tube. The sample of the bromine or iodine was prepared in deuterated solvent and 
diluted to a known volume in a volumetric flask. The amount of halogen sample for 0.25 
equivalents was calculated and the samples prepared by adding the necessary aliquots of halogen 
to the 1 mL cobaloxime samples to get 0, 0.25, 0.5, 0.75, 1, and 2 equivalents of halogen in the 
test tubes. For each test tube, 100 µL of solution was removed and used to prepare a GCMS 
sample. The remaining 900 µL were transferred to an NMR tube and the proton spectra obtained 
for each titration sample. The 1H NMR data was then analyzed to determine how many products 
arose as the titration of the halogen progressed to higher equivalents.  
3.0 Results and Discussion 
This section discusses the synthesis of the compounds used in this project, the X-ray 
structure analysis performed, and the results from the halogen cleavage titrations of the 
cobaloximes. The syntheses that are covered in this section include: Grignard synthesis of the 
tetraaryltin complexes, the successful and unsuccessful attempts at redistribution of the 
tetraaryltin species to obtain the chlorotriaryltin complexes, and the synthesis of the cobaloximes 
using the chlorotriaryltin complexes. It also discusses the basic synthesis of cobaloximes, the one 







3.1 Synthesis and Characterization of Compounds 
3.1.1 Synthesis of Cobaloximes  
The Tada method for synthesis of cobaloximes was adapted for the synthesis of (4-t-
BuPy)Co(DH)2SnPh3 by Stolzenberg, et. al.32, 37 The synthesis of this cobaloxime is described in 
Scheme 2. The procedure begins with the reaction of cobaltous chloride hexahydrate with 
dimethylglyoxime (DMG) in acetone under aerobic conditions, resulting in Co(DH)(DH2)Cl2 
crashing out as the major product.36 The dichloro cobaloxime is then suspended in methanol 
under aerobic conditions and heated to about 60 ºC with stirring. This suspension is then mixed 
with tri-n-butyl amine that helps to dissolve the dichloro cobaloxime and deprotonate the 
cobaloxime before the base is added. The base, 4-t-butylpyridine (4-t-BuPy), is then added to the 
solution along with a little water. We chose to use 4-t-BuPy instead of the more common 
pyridine due to the improved solubility of these compounds with this base and the simplification 
CoCl2 
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Scheme 2: Synthesis of (4-t-BuPy)Co(DH)2SnPh3 
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of the 1H NMR spectra.33-35 The product crashes out of solution slowly overnight and can then be 
recrystallized before the final step of the synthesis.  
The (4-t-BuPy)Co(DH)2Cl is then dissolved in methanol under a nitrogen environment and 
placed in an ice bath. The solution of 4.4 M NaOH is added to help deprotonate the cobaloxime 
and reduce the amount of NaBH4 needed during the reaction. This smaller amount of sodium 
borohydride helps to prevent the production of hydrogen gas in the reaction. The cobalt center 
then reduces to Co(I) upon the addition of sodium borohydride and the chlorotriphenyl tin is then 
added. The reaction flask is covered in aluminum foil to exclude light during the reaction. After 
removing the ice bath, the flask is allowed to stir and come to room temperature overnight. 
During this time, the (4-t-BuPy)Co(DH)2SnPh3 is formed. The compound is extracted in 
dichloromethane, dried and the solvent removed by vacuum to obtain the crude product. The 
crude product is then run through a florisil column using a 4:1 dichloromethane: ethyl acetate 
eluting solvent system. The product is obtained as orange-red crystals. About 60% yield is 


















































Upon reaction with halogen (I2 or Br2), (4-t-BuPy)Co(DH)2SnPh3 formed multiple products 
in the 1H NMR. This means that the cobaloxime is not reacting the same way as the porphyrin in 
regards to Co-Sn bond cleavage with halogen. The halogen cleaves the Co-Sn bond of the 
Co(OEP)SnPh3 cleanly, as seen in Scheme 3, but the triphenyl tin cobaloxime does not. The 
halogen is cleaving the Sn-C bond through electrophilic aromatic substitution instead of 
homolytically cleaving the desired Co-Sn bond.  
The project then progressed to explore modifying the coordination environment of the 
cobalt. One way that this was explored was through attempts to change the group 14 element 
from tin to germanium, silicon, or lead. The lead analogue was previously synthesized and 
characterized in the group, but the germanium and silicon analogues are inaccessible in our 
hands. In attempts to obtain the germanium analogue, benzyl cobaloxime was synthesized in 
order to react with HGePh3 to form toluene and (4-t-BuPy)Co(DH)2GePh3. The synthesis of 
benzyl cobaloxime, (4-t-BuPy)Co(DH)2Bn, and the proposed synthesis of (4-t-
BuPy)Co(DH)2GePh3 is seen in Scheme 4. The benzyl cobaloxime is synthesized through a one-
step procedure.39 The (4-t-BuPy)Co(DH)2Cl and benzyl chloride are mixed in a methanol and 
water solution under nitrogen. The cobaloxime is reduced by NaBH4 which is added slowly in 
several portions over about 15 minutes. The solution is allowed to stir and react for a few more 
minutes and then can be isolated through vacuum filtration and washed with ether and hexanes. 
The orange product is obtained in approximately 50% yield. The 1H NMR is consistent with the 
structure. Although reactions of benzyl cobaloxime and HGePh3 were unable to produce isolable 




 Another modification to the coordination environment of the cobalt that was explored 
was altering the Lewis base. Attempts to synthesize (2-MePy)Co(DH)2Cl, (4-MePy)Co(DH)2Cl, 
and (2,6-dimethylpyridine)Co(DH)2Cl were unsuccessful, but the synthesis of (NH3)Co(DH)2Cl 
was successful. This compound was then used to synthesize (NH3)Co(DH)2SnPh3 which was 
explored as a route to a five coordinate cobaloxime to compare to the five coordinate alkyl cobalt 
porphyrin complex. Attempts to drive off the ammonia group by heating were unsuccessful, but 
should be revisited in the future. The ammonia cobaloxime was synthesized through the same 
one-step procedure as benzyl cobaloxime and a preliminary crystal structure analysis was 

















































performed. The synthesis of both (NH3)Co(DH)2Cl and (NH3)Co(DH)2SnPh3 is seen in Scheme 
5.  
 
The (NH3)Co(DH)2Cl was synthesized by reacting dimethylglyoxime, [Co(NH3)5Cl]Cl2, 
and ammonium acetate in water and acetic acid. The reaction was heated to 100ºC and acetic 
acid was added periodically until no ammonia gas was detectible by litmus. The solid was 
collected by vacuum filtration and obtained in 55% yield. The (NH3)Co(DH)2Cl was then reacted 
in a one-step procedure with ClSnPh3 and NaBH4 in degassed methanol. The reaction flask was 
allowed to stir for several minutes and the solid was collected by vacuum filtration and washed 
with ether and hexanes. The product was an orange solid obtained in 50% yield. Its 1H NMR was 











































Scheme 5: Synthesis of (NH3)Co(DH)2SnPh3 
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3.1.2 Synthesis of Tetraaryltin Compounds  
The hypothesis of this project is that sterically hindering access to the Sn-C bond through 
substitution on the para position of the phenyl ring will promote Co-Sn bond cleavage. In order 
to test this hypothesis, aryl para-substituted cobaloximes are required. These aryl para-
substituted cobaloximes are achieved through the synthesis of chlorotriaryltin complexes that are 
then reacted with (4-t-BuPy)Co(DH)2Cl to produce the desired product.  
 
The retrosynthetic analysis for the synthesis of these chlorotriaryltin compounds is 
represented in Scheme 6. The chlorotriaryltin complex is formed from the redistribution reaction 
of the corresponding tetraaryltin compound. This tetraaryltin compound is synthesized from a 


















The first step to this synthetic route is to perform the Grignard reaction. The reaction for 
tetra-p-tolyl tin shown in Scheme 7.43 The tetraaryltin compounds that are synthesized from this 
step include tetra-C6H4-p-tolyl tin, tetra-C6H4-p-anisole tin, and tetra- C6H4-p-t-butyl tin 
represented by the formulas Sn(C6H4-p-tolyl)4, Sn(C6H4-p-OCH3)4, and Sn(C6H4-p-tBu)4 
respectively. The synthesis is carried out under nitrogen and begins with the mixing of 4-
bromotoluene and magnesium turnings in THF. Two crystals of I2 are added to help initiate the 
reaction and the flask is brought to reflux for two hours. After the reflux period is complete, the 
grayish solution is transferred under nitrogen to another flask and away from any unreacted 
magnesium. The flask is then cooled in an ice bath and tin tetrachloride (SnCl4) is added slowly 
to the Grignard reagent. The mixture is brought back up to reflux for another twelve hours. At 
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Scheme 7: Synthesis of tetra-p-tolyl tin 
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and the washing of the solution with 1 M HCl produced a yellow solution. The yellow solution 
was then cooled in a freezer for several hours and a white solid product formed and was obtained 
through filtration. The solid was rinsed with methanol and 1 M HCl. Several crops of crystals 
can be obtained from the solution. The product can be recrystallized by dissolving the solid in 
warm toluene and layering with ethanol. The melting point and 1H NMR of the product are 
consistent with literature. The synthesis of Sn(C6H4-p-OCH3)4 and Sn(C6H4-p-t-Bu)4 follow the 
same procedure and result in white crystalline solids in good yield that have NMR spectra 
consistent with their structures. During the preparation of Sn(C6H4-p-OCH3)4 one of the crops of 
solid that crashed out was hexa-C6H4-p-anisole ditin, as determined by 1H NMR and melting 
point. An attempt to cleave this using halogen to obtain the chlorotriaryltin species was 
unsuccessful. 
3.1.3 Synthesis of TriaryltinCl Compounds 
With the tetraaryl tin species in hand, the redistribution reaction to form the 
chlorotriaryltin complexes was attempted. Several unsuccessful methods (Kocheshkov, 
Chambers and Scherer, Krause, and a 3:1 Grignard reaction) were explored before a successful 
procedure (Jolly) for the redistribution reaction was found.38, 43-45 All attempts at redistribution 
were made first using Sn(C6H4-p-tolyl)4 and if successful the other two tetraaryl tin complexes 





The first attempt at redistribution involved the Kocheshkov reaction, shown in Scheme 
8.38 In a 3:1 mole ratio of Sn(C6H4-p-tolyl)4 to SnCl4, these two compounds are mixed in a test 
tube and heated in an oil bath at 205 ºC for three hours. The temperature is then dropped to 160 
ºC for another three hours and the solution is then cooled. Upon cooling, a solid should 
crystallize and can then be rinsed in boiling ether and filtered. The ether washings are then 
concentrated under vacuum and the resulting solid mass filtered. The solid can then be 
recrystallized using ethanol. After cooling the solution following its heating to 160 ºC, little 
product was observed. After proceeding through with the washings in ether very little product 
remained. The 1H NMR showed very little compound and was overwhelmed by mainly solvent 
peaks and some impurities. Attempts were also made using SnI4 instead of SnCl4 due to the ease 
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The next attempt at the redistribution reaction involved a method from Chambers and 
Scherer, seen in Scheme 9.44 This synthetic approach involved a 1:1 mole ratio of Sn(C6H4-p-
tolyl)4 to iodine. Each reagent was dissolved in chloroform, combined and heated to produce the 
iodotriaryltin species. This step never resulted in a pure isolable product. From this step, one 
could convert it to the bromotriaryltin complex by dissolving in ether and adding three portions 
of 30% NaOH and concentrated HBr. The solutions are dried using sodium sulfate, filtered and 
the solvent concentrated using rotary evaporation. The product could be recrystallized from 
petroleum ether resulting in about 50% yield.  
 The third attempt at redistribution involved the Krause method, seen in Scheme 10.45 
This method began by dissolving Sn(C6H4-p-tolyl)4 in hot pyridine and stirring. The solution is 
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0.5 g, 0.001026 mol
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0.2508 g, 0.001026 mol
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Scheme 9: Chambers and Scherer redistribution synthetic attempt 
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Br2 in pyridine added in six aliquots over a few hours. The pyridine and bromobenzene is 
removed by vacuum and a brown residue remains. This residue is dissolved in ether and then 
reacted with concentrated HCl. The ether solution is filtered and the solvent was removed with a 
rotary evaporator to yield the crude chlorotriaryltin product. This crude product is then dissolved 
in ether and washed with 30% NaOH. It is then washed with concentrated HCl and purified in 
warm ether to yield ClSn(C6H4-p-tolyl)4. The crude product was never obtained through multiple 
attempts of this procedure. This is not a viable option for the redistribution of the substituted 
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wash with 30% NaOH
wash with conc. HCl
purify in warm ether
Scheme 10: Krause method for redistribution synthetic attempt 
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 The next synthetic route investigated was a 3:1 Grignard reaction, seen in Scheme 11.43 
The ratio was expected to limit the available Grignard reagent in hopes of leading to only three 
of the chlorines being displaced from the SnI4 and producing ISn(C6H4-p-tolyl)3 which can then 
be used to synthesize the substituted cobaloxime. The synthesis of the Grignard reagent follows 
the same procedure as used in the tetraaryltin syntheses. The next step in the synthesis is similar 
as well, except the ratio of the Grignard reagent to the SnI4 has been altered to 1:3. This synthesis 
produced many products that were not easily isolated. The main product was still the tetraaryltin 
species. This method is not a feasible route to obtain the chlorotriaryltin compounds.  
 
 The final redistribution method was developed by Jolly and led to the successful 
synthesis of ClSn(C6H4-p-tolyl)3 and ClSn(C6H4-p-t-Bu)3, as seen in Scheme 12.38 The 
ClSn(C6H4-p-OCH3)3 was not successfully synthesized by this method or any other methods. It is 






Br17.63 mL, 0.140 mol
















Transfer, cool in ice
add 4.38 g (0.007 mol)  SnI4
reflux 12 hrs
Filter
wash with 1M HCl and MeOH
Scheme 11: 3:1 Grignard in an attempt to synthesize ClSn(C6H4-p-tolyl)3 
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preventing the redistribution of the phenyl group. The Jolly procedure is a variation on the 
Kocheshkov procedure, but the reaction is done at higher temperatures and the work up of the 
solid product is handled differently. The Sn(C6H4-p-tolyl)4 is added to a reaction tube along with 
SnCl4 and the tube is heated to 230 ºC slowly over a period of 1.5 hours. The temperature is held 
for three hours and then cooled to 100 ºC. When this temperature is reached, the solution is 
poured into a beaker and cooled to room temperature. The solid mass is broken up and stirred 
with warm ethanol at about 50 ºC. Water is added slowly to crash out the desired product. The 
white solid is then filtered and allowed to air dry. This procedure leads to a reasonably pure 
product in decent yield, but can be recrystallized to improve the purity of the sample. This 
procedure afforded us the desired chlorotriaryltins, ClSn(C6H4-p-tolyl)3 and ClSn(C6H4-p-t-Bu)3. 
From here the substituted chlorotriaryltin compounds were reacted using a procedure analogous 
to the synthesis of (4-t-BuPy)Co(DH)2SnPh3 discussed above. The reaction of both of these 
compounds with (4-t-BuPy)Co(DH)2Cl afforded the desired products of (4-t-
BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 and (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. The reactivity of 
these substituted cobaloximes was examined through NMR titrations with halogen, described in 







3) cool to 100
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Scheme 12: Jolly procedure for the successful redistribution of Sn(C6H4-p-
tolyl)4 to ClSn(C6H4-p-tolyl)3 
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3.2 X-ray Structure Analysis of Cobaloxime Tin Complexes 
3.2.1 X-ray Analysis of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 
A crystal structure of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 was determined. An ORTEP 
drawing of the structure is shown in Figure 4. The crystal data is represented in Table 2. Table 3 
contains the data collection and structure refinement parameters and Table 4 contains selected 
interatomic distances and bond angles for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3.  The compound 
crystallizes in the centrosymmetric triclinic space group P-1 with two compounds in the unit cell. 
The cobalt is a six coordinate octahedral atom that is connected to the four donor nitrogen atoms 
Figure 4. ORTEP drawing of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3. Perspective view of the 
molecular structure of one of the two crystallographic independent molecules of (4-t-
BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 with the atom labeling scheme for the non-hydrogen 
atoms.  The thermal ellipsoids are scaled to enclose 30% probability. 
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from dimethylglyoxime (DMG) in the equatorial plane and to the tin and nitrogen of the 4-t-
Bupyridine in the axial positions. Each of the DMG ligands is chelated in a bidentate fashion 
through the donor nitrogen atoms to the cobalt center. The DMG ligands are connected to each 
other through two bridging O—H⸱⸱⸱O hydrogen bonds.  
The equatorial Co-N bonds have interatomic distances that range from 1.874(3) – 1.880(3) Å. 
This is comparable to the equatorial Co-N interatomic distances for the coenzyme B12 (~1.90 Å), 
vitamin B12 (~1.92 Å), and alkyl cobaloxime (~1.88 Å).7, 14 The alkyl cobaloxime that is 
referenced is the first alkyl cobaloxime studied by Lenhert in 1967, PyCo(DH)2CH2COOCH3. 
The equatorial Co-N bonds for CoIII(OEP)SnPh3 are slightly longer (1.962 – 1.975 Å) than (4-
tBuPy)Co(DH)2Sn(C6H4-p-tolyl)3.26  
The axial Co-N bond for the 4-t-BuPy is 2.063(3) Å. This is similar to the bond distances in 
vitamin B12 (1.97 – 2.06 Å) and alkyl cobaloxime (~2.04 Å), but is shorter than the axial Co-N 
bond in coenzyme B12 (2.24 Å).7, 14 The increased length in the axial Co-N bond in the coenzyme 
is believed to come from the cobaloxime having a slightly greater positive charge on the cobalt 
center than in the coenzyme. 
The axial Co-Sn bond for the Sn(p-tolyl)3 is 2.5746(6) Å. It is slightly longer than the axial 
Co-Sn bond from CoIII(OEP)SnPh3 (2.510 Å), and is much longer than the axial Co-C bonds 
from coenzyme B12 (2.03 Å), vitamin B12 (1.92 Å), and alkyl cobaloxime (2.04 Å). 7, 14, 26 The 
large bond distance for Co-Sn in (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 likely arises from the 




Table 2.  Crystal data for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3  
 
Chemical formula C38H48CoN5O4Sn 
Formula weight 816.43 
Temperature 296(2) K 
Wavelength 0.71073 Å 
Crystal size 0.112 x 0.156 x 0.408 mm 
Crystal system triclinic 
Space group P -1 (No. 2) 
Unit cell dimensions a = 13.2949(5) Å α = 107.1983(13)° 
 b = 17.7508(7) Å  β = 91.6597(13)° 
 c = 18.2240(7) Å  γ = 107.6992(12)° 
Volume 3880.5(3) Å3  
Z 4  
Density (calculated) 1.397 g/cm3 
Absorption coefficient 1.115 mm-1 
F(000) 1680 
 
Table 3.  Data collection and structure refinement for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 
Theta range for data collection 2.75 to 27.50° 
Index ranges -17 ≤ h ≤ 16, -23 ≤ k ≤ 23, -23 ≤ l ≤ 23 
Reflections collected 97231 
Independent reflections 17647 [R(int) = 0.0576] 
Coverage of independent 
reflections 99.0% 
Absorption correction multi-scan 
Max. and min. transmission 0.885 and 0.659 
Refinement method Full-matrix least-squares on F2 
Refinement program SHELXL-2013 (Sheldrick, 2013) 
Data / restraints / parameters 17647 / 6 / 950 
Goodness-of-fit on F2 1.103 
Final R indices 11275 data; I>2σ(I) R1 = 0.0647, wR2 = 0.0880 
 all data R1 = 0.1061, wR2 = 0.0956 
Largest diff. peak and hole 1.054 and -0.657 e-/Å3 
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Table 4: Selected interatomic distances (Å) and bond angles (°) for (4-t-BuPy)Co(DH)2Sn(C6H4-
p-tolyl)3 
Selected Interatomic Distances    
Sn1-C25 2.153(4) Sn1-C32 2.163(4) 
Sn1-C18 2.170(4) Sn1-Co1 2.5746(6) 
Co1-N4 1.874(3) Co1-N2 1.875(3) 
Co1-N3 1.875(3) Co1-N1 1.880(3) 
Co1-N5 2.063(3)   
   
Selected Bond Angles   
C25-Sn1-C32 105.99(17) C25-Sn1-C18 106.08(17) 
C32-Sn1-C18 101.28(16) C25-Sn1-Co1 112.52(11) 
C32-Sn1-Co1 119.39(12) C18-Sn1-Co1 110.32(11) 
N4-Co1-N2 175.45(14) N4-Co1-N3 81.44(15) 
N2-Co1-N3 99.20(15) N4-Co1-N1 98.24(14) 
N2-Co1-N1 80.77(15) N3-Co1-N1 175.54(14) 
N4-Co1-N5 92.56(13) N2-Co1-N5 91.92(13) 
N3-Co1-N5 91.78(13) N1-Co1-N5 92.68(13) 
N4-Co1-Sn1 89.28(10) N2-Co1-Sn1 86.22(10) 
N3-Co1-Sn1 90.13(10) N1-Co1-Sn1 85.42(10) 
N5-Co1-Sn1 177.52(9)   
 
3.2.2 Preliminary X-ray Analysis of (NH3)Co(DH)2SnPh3 
The crystal structure was also obtained for the cobaloxime with ammonia as a labile base, 
NH3Co(DH)2SnPh3. This compound was synthesized in an effort to obtain a five coordinate 
cobaloxime through the dissociation of the ammonia. The goal of this synthesis was to develop a 
cobaloxime with the same coordination environment as the organotin porphyrin complexes to see 
if this change in the structure of the cobaloxime would result in clean cleavage of the Co-Sn 
bond by oxidation with halogen. This compound was synthesized by a one-step cobaloxime 
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procedure described in the experimental, but efforts to obtain the five coordinate cobaloxime by 
heating to 60-70 ºC to drive off the NH3 have been unsuccessful. 
The quality of the crystal structure analysis of this complex, although limited, was sufficient 
to verify the atom connectivity of this ammonia adduct. The cobalt complex, as depicted in 
Figure 5, is six coordinate with the octahedral coordination sphere containing ammonia, tin and 
four donor nitrogens from the two dimethylglyoxime ligands. The ammonia and tin are located 
in the axial positions with the four donor nitrogens of the dimethylglyoxime ligands in the 
equatorial plane.  The analysis showed that the lattice contained a disordered solvent. The 
bridging hydrogens that connect the two dimethylglyoxime ligands through O-H-O hydrogen 
bonds were unable to be resolved in this structure. The crystal structure is not resolved well 
enough for publication, but is sufficient to demonstrate the connectivity of the 
NH3Co(DH)2SnPh3. 
Figure 5: ORTEP drawing of (NH3)Co(DH)2SnPh3. Perspective view of 
the molecular structure of (NH3)Co(DH)2SnPh3, where DH = 
ONC(Me)=C(Me)NOH, with the atom labeling scheme for the non-
hydrogen atoms. The thermal ellipsoids are scaled to enclose 30% 
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3.3 Halogen Cleavage Titrations 
This section discusses the halogen cleavage reactions of the synthesized cobaloximes. The 
Co(OEP)SnPh3 cleaves the Co-Sn bond cleanly upon addition of halogen, as seen in Scheme 3.26 
The (4-t-BuPy)Co(DH)2SnPh3 was seen to form multiple products upon the addition of halogen 
and did not cleave the Co-Sn bond cleanly. Instead, the cleavage of the Sn-C bond of the phenyl 
ring through electrophilic aromatic substitution was observed, as seen in Scheme 3. The purpose 
of this project is to develop a system for the cobaloxime, through tuning its environment, that 
will allow it to exhibit clean homolytic Co-Sn bond cleavage. If this is achieved, the system may 
help us to understand the differences in reactivity of the porphyrins and cobaloximes. The 
hypothesis of this project was that substitution on the para position of the phenyl rings attached 
to the tin could change the donor strength and may promote Co-Sn bond cleavage. The para 
substituted cobaloximes were successfully synthesized and the halogen cleavage reactions 
discussed in this section will test this hypothesis. 
The following halogen cleavage reactions have been performed to date: (Py)Co(DH)2SnPh3, 
(4-t-BuPy)Co(DH)2SnPh3, (NH3)Co(DH)2SnPh3, (4-CNPy)Co(DH)2SnPh3, (4-t-
BuPy)Co(DH)2Sn(C6H4-p-tolyl)3, and (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. A former group 
member also ran a halogen cleavage titration with (4-t-BuPy)Co(DH)2Sn(n-Bu)3. The halogen 
cleavage titrations were performed on the NMR scale using I2 or Br2 and measuring the 1H NMR 
spectra for every determined amount of equivalents. The (4-t-BuPy)Co(DH)2Sn(n-Bu)3 did 
exhibit clean cleavage of the Sn-Co bond, but may not provide enough information about the 
differences in the porphyrin and cobaloxime system since it is an alkyl tin ligand and not an 
aryltin ligand attached to the cobalt center. The alkyl tin does not translate well to the lead 
analogue due to toxicity issues, so comparison across group 14 elements is better served by the 
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aryl tin ligand cobaloximes. All of the triaryltin cobaloximes exhibited cleavage of the Sn-C 
bond instead of clean cleavage of the Co-Sn bond. Although all of these cobaloximes showed 
multiple products developing in the NMR as the halogen was added, the halogen titration of (4-t-
BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 had less overlap due to the p-t-Bu group. To provide an 
example of the nature of the halogen cleavage reactions for the cobaloxime tin complexes, the 
experimental results are described for the bromine titration and the corresponding 1H NMR 
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Figure 7: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The O—
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19.74 19.44 19.18 18.86 
Figure 8: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The O—H⸱⸱⸱O 
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Figure 9: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The O—H⸱⸱⸱O 





Figure 10: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The alkyl region 0 eq Br2. 
Initial 







Figure 11: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1













Figure 12: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1















Figure 13: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1


















Figure 14: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
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Figure 15: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
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Figure 16: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The aromatic region for 0 
equivalents of Br2. 
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Figure 17: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The aromatic region for 0.25 
equivalents of Br2. 


































* Starting Material 
Figure 18: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The aromatic region for 0.5 
equivalents of Br2. 
















* Starting Material 
Figure 19: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The aromatic region for 0.75 
equivalents of Br2. 





























* Starting Material 
Figure 20: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The aromatic region for 1 
equivalent of Br2. 












* Starting Material 
Figure 21: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 
1
H NMR in C6D6. The aromatic 
region for 2 equivalents of Br2. 





The (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 was dissolved in C6D6 and the concentration 
determined. Seven test tubes received 1 mL of the cobaloxime solution and bromine was added 
to the test tubes in order to obtain samples with 0, 0.25, 0.5, 0.75, 1, and 2 eq. of bromine. An 
aliquot of 100 µL was removed from each sample to prepare a GCMS sample in benzene. The 
remaining 900 µL of solution went into an NMR tube and the proton spectra was obtained. The 
Figures 6-15 are broken into the different regions of the spectra for each equivalent of bromine. 
Figure 6 provides the overall structure (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 and the initial 
spectra for the compound. Figures 7 – 9 cover the O—H⸱⸱⸱O region around 19 ppm, Figures 10 – 
12 cover the alkyl region from 0 – 2.5 ppm, and Figures 13 – 15 cover the aromatic region from 
6 – 9 ppm.  
Figure 6 displays the initial structure of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. This 
compound has very distinct peaks and is more resolved than some of the other cobaloximes that 
tend to have overlapping and crowding in the aromatic region. The compound has 8 distinct 
peaks corresponding to the 75 hydrogens in the structure. In the alkyl region, the three peaks 
correspond to the t-Bu group of the pyridine (0.64 ppm, s, 9 H), the t-Bu groups on the phenyl 
rings attached to the tin (1.22 ppm, s, 27 H), and the methyl groups on the DMG ligand (1.63 
ppm, s, 12 H). In the aromatic region there are four peaks that correspond to the β protons of the 
pyridine ring (6.56-6.54 ppm, dd, 2 H), the m-H of the phenyl rings (7.28-7.26 ppm, dd, 6 H), the 
o-H of the phenyl ring (7.95-7.93 ppm, dd, 6 H), and the α protons of the pyridine ring (8.93-
8.91 ppm, dd, 2 H). The final region is the O—H⸱⸱⸱O hydrogen bonds that appear at 19.74 ppm 
as a broad singlet of 2 H. These NMR peaks, integrations and chemical shifts are consistent with 
the structure. There is also a strong solvent peak for C6D6 at 7.16 ppm with 13C satellites 




Figures 7 through 9 contain the O—H⸱⸱⸱O bonding region around 19.7 ppm for 0, 0.25, 0.5, 
0.75, 1, and 2 equivalents of bromine. The initial peak for the bridging hydrogen is at 19.74 ppm. 
At 0.25 equivalents of bromine, two more bridging hydrogen peaks are present at 19.44 and 
19.18 ppm. These new peaks correspond to a new cobaloxime being formed through cleavage of 
a C-Sn bond by the halogen. At 0.5 equivalents of bromine, the starting compound peak at 19.74 




































Scheme 13: Proposed Reaction of Halogen with Triaryltin Cobaloxime 
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bromine, the 19.74 and 19.44 ppm peaks have almost disappeared and the 19.18 and 18.86 ppm 
peaks have increased. At 1 equivalent of bromine, the 19.74 and 19.44 ppm peaks are completely 
gone and the 19.18 ppm peak has decreased in relation to the 18.86 ppm peak. At 2 equivalents 
of bromine, the only peak that remains is the 18.86 ppm peak. The 19.74 ppm corresponds to the 
initial cobaloxime and the new peaks 19.44, 19.18, and 18.86 ppm correspond to the new 
cobaloxime products. Through GCMS studies it is determined that 1-bromo-4-t-butylbenzene is 
the main product formed upon addition of bromine and the concentration of the peak increases as 
the equivalents of bromine increase. This product would arise from the cleavage of the Sn-C 
bond by bromine as seen in Scheme 13 below. The peaks corresponding to 19.44, 19.18 and 
18.86 ppm arise from the Sn-C cleavage and production of Ar-Br bonds.   
Figures 10 – 15 contain the 1H NMR spectra for the alkyl region. The initial peaks are the t-
Bu group of the pyridine (0.64 ppm, s, 9 H), the t-Bu groups on the phenyl rings attached to the 
tin (1.22 ppm, s, 36 H), and the methyl groups on the DMG ligand (1.63 ppm, s, 12 H). This 
region behaves similar to the bridging hydrogen region upon addition of bromine. The clearest 
example in this region is the t-butyl peak of the phenyl rings. The initial peak is at 1.22 ppm and 
upon addition of 0.25 equivalents of bromine, three new peaks are observed (1.19, 1.13, 1.06 
ppm). For the 0.5, 0.75, and 1 equivalents of bromine spectra all four peaks are still visible, but 
the more downfield peaks have significantly decreased in intensity and the 1.06 ppm peak is the 
most dominant. After 2 equivalents of bromine, the dominant peak is 1.06 ppm and the initial 
peak of 1.22 ppm and the 1.13 ppm peaks are still observed, but the 1.18 ppm peak has 
disappeared. The 1.06 ppm peak corresponds to the tert-butyl group of the 1-bromo-4-t-
butylbenzene organic product that is formed from the Sn-C bond cleavage. This peak increases in 
intensity as the equivalents of bromine increase and can indicate that the three bonds of the Sn-C 
 
58 
may be cleaved in succession upon addition of the bromine and lead to an increasing amount of 
BrAr cleavage product being present. A proposed set of reactions for this compound is seen in 
Scheme 13 with a focus on Sn-C cleavage. The three new cobaloxime products seen in the 
bridging region could be consistent with the formation of (4-t-BuPy)Co(DH)2SnAr2Br, (4-t-
BuPy)Co(DH)2SnArBr2 and (4-t-BuPy)Co(DH)2SnBr3 as the bromine titration progresses. 
Another option could be that Co-Sn bond cleavage may be possible after the cleavage of some of 
the Sn-C bonds due to changes in the electronic environment of the tin ligand. The exact 
products for these peaks can be suggested, but cannot be confirmed without the synthesis and 
characterization of the possible intermediates outlined in Scheme 13. One can infer that since the 
Sn-C bond is preferentially cleaved, the Sn-C bond cleavage with halogen is more facile than the 
Co-Sn bond with this set of compounds. 
 Figures 16 – 21 contain the aromatic region for the halogen cleavage titration. This 
spectral region gets more crowded, but the same behavior can be seen with the pyridine and 
phenyl peaks.  Several new products are growing into the aromatic region of the cobaloxime as 
the bromine is added, but as the titration progresses some peaks are harder to resolve. Although 
this spectral region is not as clear as the bridging hydrogen and alkyl regions, we can still 
monitor the formation of the cleavage product 1-bromo-4-t-butylbenzene. The cleavage product 
has aromatic peaks 7.29-7.27 and 6.91-6.89 ppm. These peaks behave similarly to the t-Bu peak 
in the alkyl region and increase in intensity as the bromine is added in increasing equivalents. 
This preference for the Sn-C bond cleavage is demonstrated in this region as well and the 





Several six-coordinate cobaloxime compounds containing a triaryltin ligand were 
synthesized and characterized. The susceptibility of these cobaloximes to halogen cleavage was 
investigated. The multiple products formed through these halogen cleavage reactions indicates 
that the Co-Sn bond is not readily cleaved cleanly for these cobaloximes, unlike the reactivity 
observed with the alkyl and tin porphyrin complexes. The cobaloximes react with the halogens to 
first cleave the Sn-C bonds through electrophilic aromatic substitution, which indicates that the 
Sn-C bond cleavage is more facile than the Co-Sn cleavage for this set of compounds. The 
alteration of the para substituent on the phenyl rings to change donor ability of the Sn-C bonds 
and alter the electronic environment in attempts to promote Co-Sn cleavage was unsuccessful. 
The ultimate goal of this work is to find a cobaloxime system, containing a triaryltin ligand, that 
will have clean cleavage of the Co-Sn bond so it can be compared to the porphyrin system to 
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